Related Articles
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer
Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer
Combination therapy with antibody‑drug conjugate RC48 (disitamab vedotin) and zimberelimab (PD‑1 inhibitor) successfully controlled recurrent HER2‑positive breast cancer resistant to trastuzumab emtansine: A case report
A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells
Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review)